Project Details
Description
Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Subcutaneously Administered Efgartigimod with rHuPH20 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
| Status | Active |
|---|---|
| Effective start/end date | 6/1/22 → 5/31/27 |
Funding
- ARGENX
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.